The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
----------
Shield Therapeutics PLC -...
Feb 22, 2024 / 02:00PM GMTPresentationFeb 22, 2024 / 02:00PM GMT =====================Corporate Participants===================== * Gregory P. Madison S
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
----------
Comptoir Group PLC - Owner and operator of a chain of...
The dynamics of the iron deficiency anemia market are anticipated to change in the coming years owing to the improvement in the research and development...
Shield Therapeutics PLC on Tuesday said it has now completed its USD20 million senior secured debt facility from SWK Funding LLC.
Shield Therapeutics is a Gateshead Quays, England-based commercial...
/PRNewswire/ -- The iron drugs market size is forecast to increase by USD 3,552.86 million from 2022 to 2027, at a CAGR of 9.41%, according to the recent...
The following stocks are the leading risers and fallers on AIM in London on Thursday.
----------
AIM - WINNERS
----------
Genedrive PLC, up 34% at 33.47 pence, 12-month range 8p-42p. The molecular... | February 9, 2023
The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
----------
DeepVerge PLC - Dublin-based environmental and life science... | January 9, 2023
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
----------
Cap-XX Ltd - Sydney-based maker of ultra-thin prismatic... | December 13, 2022
Ferric Carboxymaltose to Generate nearly 50% of the Intravenous Iron Drugs Market throughout the Analysis Period. The US market for Intravenous Iron Drugs...
LONDON, June 21, 2021 (GLOBE NEWSWIRE) — Shield Therapeutics PLC (STX.L), based in Newcastle-upon-Tyne, UK, focused on addressing iron deficiency with its…